Antzela Tsavou
Senior Scientist
Antzela joined VirTus as a Senior Scientist in September 2024, after contributing to the company’s projects as a consultant for the past three years.
She completed her BSc in Biomedical Sciences in 2018, followed by an MSc in Molecular Medicine from Imperial College London. During her MSc, Antzela conducted research in Professor Charles Bangham’s lab, where she investigated the impact of human T-cell leukemia virus (HTLV-1) on host chromatin structure and transcription. Her passion for understanding host-pathogen interactions led her to join Professor Julian Naglik’s group at King’s College London as a Research Assistant, where she contributed to several collaborative projects, resulting in publications.
Antzela went on to pursue a PhD in Infectious Diseases at the Centre for Host-Microbiome Interactions at King’s College London, focusing on understanding the pathogenicity and commensalism mechanisms of Candida albicans clinical isolates. Over the past six years, she has developed extensive proficiency in a wide range of molecular, cellular and immunological laboratory techniques both in vitro and in vivo.
As a Senior Scientist at VirTus, Antzela will be involved in conducting laboratory research, interpreting data, and designing experiments ensuring scientific rigor and innovation.
Antzela Tsavou
Senior Scientist
Antzela joined VirTus as a Senior Scientist in September 2024, after contributing to the company’s projects as a consultant.
She completed her BSc in Biomedical Sciences in 2018, followed by an MSc in Molecular Medicine from Imperial College London. During her MSc, Antzela conducted research in Professor Charles Bangham’s lab, where she investigated the impact of human T-cell leukemia virus (HTLV-1) on host chromatin structure and transcription. Her passion for understanding host-pathogen interactions led her to join Professor Julian Naglik’s group at King’s College London as a Research Assistant, where she contributed to several collaborative projects, resulting in publications.
Antzela went on to pursue a PhD in Infectious Diseases at the Centre for Host-Microbiome Interactions at King’s College London, focusing on understanding the pathogenicity and commensalism mechanisms of Candida albicans clinical isolates. Over the past six years, she has developed extensive proficiency in a wide range of molecular, cellular and immunological laboratory techniques both in vitro and in vivo.
As a Senior Scientist at VirTus, Antzela will be involved in conducting laboratory research, interpreting data, and designing experiments ensuring scientific rigor and innovation.
